VIVO Cannabis Inc.

DB:23Q Rapporto sulle azioni

Cap. di mercato: €6.3m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

VIVO Cannabis Gestione

Gestione criteri di controllo 3/4

Informazioni chiave

Ray Laflamme

Amministratore delegato

CA$262.3k

Compenso totale

Percentuale dello stipendio del CEO82.0%
Mandato del CEO1.8yrs
Proprietà del CEO10.2%
Durata media del management4.3yrs
Durata media del Consiglio di amministrazione1.8yrs

Aggiornamenti recenti sulla gestione

Recent updates

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Ray Laflamme rispetto agli utili di VIVO Cannabis?
DataCompenso totaleStipendioGuadagni aziendali
Dec 31 2022n/an/a

-CA$48m

Sep 30 2022n/an/a

-CA$108m

Jun 30 2022n/an/a

-CA$105m

Mar 31 2022n/an/a

-CA$70m

Dec 31 2021CA$262kCA$215k

-CA$70m

Sep 30 2021n/an/a

-CA$45m

Jun 30 2021n/an/a

-CA$49m

Mar 31 2021n/an/a

-CA$48m

Dec 31 2020CA$276kCA$213k

-CA$56m

Sep 30 2020n/an/a

-CA$33m

Jun 30 2020n/an/a

-CA$38m

Mar 31 2020n/an/a

-CA$47m

Dec 31 2019CA$304kCA$210k

-CA$31m

Sep 30 2019n/an/a

-CA$27m

Jun 30 2019n/an/a

-CA$26m

Mar 31 2019n/an/a

-CA$13m

Dec 31 2018CA$173kCA$67k

-CA$25m

Compensazione vs Mercato: Ray's total compensation ($USD194.79K) is below average for companies of similar size in the German market ($USD422.04K).

Compensazione vs guadagni: Ray's compensation has been consistent with company performance over the past year.

AMMINISTRATORE DELEGATO

Ray Laflamme

1.8yrs

Mandato

CA$262,250

Compensazione

Mr. Joseph Louis Raymond Laflamme, also known as Ray, serves as the Director at VIVO Cannabis Inc. since April 12, 2021 and serves as its Chief Executive Officer since July 5, 2021. He serves as Chairman o...

Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Joseph Louis Laflamme
Chairman & CEO1.8yrsCA$262.25k10.22%
CA$ 645.4k
Michael Bumby
Chief Financial Officer5.3yrsCA$315.18k0.11%
CA$ 7.2k
Andreas Sander
President of European Operations4.3yrsCA$356.56kNessun dato
Carole Chan
Chief Commercial Officer & President of Harvest Medicine1.3yrsCA$261.02kNessun dato
Mariana Fonar
General Counsel & Secretary1.8yrsNessun datoNessun dato
Richa Love
Chief Medical Officer & Member of Scientific Advisory Board4.3yrsNessun datoNessun dato
Matt Patterson
Chief Commercial Officerno dataNessun datoNessun dato
Ying Guan
VP of Napanee Operations & Secretary5.9yrsCA$131.54kNessun dato
Michael Shannon
Chief Medical Consultant & Member of Scientific Advisory Board5.8yrsNessun dato0.11%
CA$ 7.2k

4.3yrs

Durata media

58yo

Età media

Gestione esperta: 23Q's management team is considered experienced (4.3 years average tenure).

Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Joseph Louis Laflamme
Chairman & CEO2yrsCA$262.25k10.22%
CA$ 645.4k
Richa Love
Chief Medical Officer & Member of Scientific Advisory Board4.3yrsNessun datoNessun dato
Michael Shannon
Chief Medical Consultant & Member of Scientific Advisory Boardno dataNessun dato0.11%
CA$ 7.2k
Glen Huber
Independent Director1.3yrsCA$12.00k0.027%
CA$ 1.7k
Shai Altman
Independent Director1.3yrsCA$10.50kNessun dato
Donald Abrams
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Christopher Hudalla
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Michael Dixon
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Paul Daeninck
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Olga Sanctis
Member of Scientific Advisory Boardno dataNessun datoNessun dato
Eric Shipman
Independent Director1.8yrsCA$33.50kNessun dato
Holly Workman
Independent Director1.8yrsCA$35.75kNessun dato

1.8yrs

Durata media

Consiglio di amministrazione esperto: 23Q's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.